RTX Corp: Form 10-Q for the period ended Jun 30, 2022
Filed with the SEC on Jul 26, 2022 and accepted by EDGAR at Jul 26, 2022, 16:25 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-04-01 to 2022-06-30 | $16.31bn | us-gaap:Revenues |
| Revenue | 6 months2022-01-01 to 2022-06-30 | $32.03bn | us-gaap:Revenues |
| Research and development | 3 months2022-04-01 to 2022-06-30 | $698.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2022-01-01 to 2022-06-30 | $1.33bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-04-01 to 2022-06-30 | $1.42bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2022-01-01 to 2022-06-30 | $2.89bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-04-01 to 2022-06-30 | $1.35bn | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2022-01-01 to 2022-06-30 | $2.43bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-04-01 to 2022-06-30 | $329.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2022-01-01 to 2022-06-30 | $647.0m | us-gaap:InterestExpense |
| Income tax | 3 months2022-04-01 to 2022-06-30 | $160.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2022-01-01 to 2022-06-30 | $276.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-04-01 to 2022-06-30 | $1.30bn | us-gaap:NetIncomeLoss |
| Net income | 6 months2022-01-01 to 2022-06-30 | $2.39bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-04-01 to 2022-06-30 | $0.88 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2022-01-01 to 2022-06-30 | $1.60 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-04-01 to 2022-06-30 | $0.88 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2022-01-01 to 2022-06-30 | $1.61 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-04-01 to 2022-06-30 | 1,489,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2022-01-01 to 2022-06-30 | 1,493,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Dividends paid | 6 months2022-01-01 to 2022-06-30 | $1.54bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2022-01-01 to 2022-06-30 | $1.78bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-06-30 | $4.77bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-06-30 | $41.46bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-06-30 | $159.02bn | us-gaap:Assets |
| Current liabilities | At period end2022-06-30 | $37.79bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-06-30 | $86.99bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2022-06-30 | $113.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2022-06-30 | $70.44bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2022-06-30 | 1,476,514,046 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000101829-22-000040. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.